Common side effects include nausea, vomiting, and diarrhea Semaglutide Wegovy 2.4 Mg Inj Request Callback 14120 / Piece Get Latest Price Product Brochure Wegovy (semaglutide) 2.4 mg is the initial, once-weekly subcutaneous injection dose for chronic weight management in adults with obesity or overweight, alongside diet and exercise
PubMed laboratory research record [PMID: 20388953] PubMed record related to this compound for laboratory literature review
Gastrointestinal side effects such as nausea, vomiting, or diarrhea can lead to fluid losses, while decreased appetite may reduce overall fluid intake
Chelsea (verified owner) Rated 5 out of 5 Margarita J
Ngoc Pham, MD *** 11013 Countryway Blvd, Tampa, FL 33626 ***Ph: 813-749-0918 *** 11013 Countryway Blvd, Tampa, FL 33626 ***Ph: 813-749-0918 WANTING TO LOSE WEIGHT
We were on hold for mere seconds, and the agent was kind, easy to hear, attentive and knowledgable